Арлет

Quick links to important sections

Арлет

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Арлет

Quick Facts

Property Description
Active ingredient Amoxicillin and Clavulanic acid
Form Tablets (film-coated, dispersible), Oral Suspension
Pharmacological class Broad-spectrum Antibiotic; beta-Lactamase Inhibitor combination
General purpose Overcomes bacterial resistance to fight infection
Origin Semi-synthetic

What Type of Medicine is Арлет and What is it Made Of?

Арлет is a trade designation for the pharmaceutical product containing the fixed-dose combination (FDC) of the International Nonproprietary Name (INN) components: Amoxicillin and Clavulanic acid. This combination is classified as a beta-Lactamase Inhibitor combined with a Broad-spectrum Antibacterial. Amoxicillin itself is a semi-synthetic derivative of the basic penicillin nucleus. This formulation is globally recognized for its efficacy and its role in public health.

General Purpose: Why is Арлет a Two-Part Combination?

The fundamental purpose of this two-part composition is to maintain the therapeutic potency of the antibiotic against bacteria that have developed resistance mechanisms. Amoxicillin, the primary agent, achieves its bactericidal action by interfering with the synthesis of the bacterial cell wall, which causes the cell to break down. However, many bacteria produce beta-Lactamase enzymes to chemically neutralize this mechanism. Clavulanic acid, the secondary component, is a beta-Lactamase inhibitor that acts as a targeted molecular shield; it irreversibly binds to and deactivates these defense enzymes. This combination ensures the antibiotic's full effectiveness is restored, enabling it to successfully target and eliminate a wider range of pathogenic microorganisms and resolve the underlying bacterial infection.

Regulatory References

  1. NIH, Clavulanic Acid - StatPearls

What side effects are possible with Арлет?

Possible Side Effects and Safety Information

Official regulatory documents categorize the safety profile of the Amoxicillin/Clavulanic acid combination (Арлет) based on the frequency of documented adverse reactions and the system or organ affected. The most frequently reported adverse reaction is Diarrhoea, which is classified as Very Common. Other reactions classified as Common include nausea, vomiting, and mucocutaneous candidosis.

Adverse effects are documented across several System-Organ Classes. These include Gastrointestinal Disorders, Hepatobiliary Disorders, Immune System Disorders, and Skin and Subcutaneous Tissue Disorders. Uncommon reactions involve headache, dizziness, indigestion, and transient rises in liver enzymes (AST and/or ALT).

Serious Adverse Reactions (SARs), while rare, are defined in official labeling. These include potentially fatal Severe Hypersensitivity Reactions (such as anaphylaxis and angioneurotic oedema) and severe skin reactions, including Stevens-Johnson syndrome (SJS) and Acute Generalised Exanthemous Pustulosis (AGEP). Hepatotoxicity (hepatitis and cholestatic jaundice) is also documented as a serious risk.

Safety constraints and patterns are noted for specific populations. Hepatic events are reported predominantly in males and elderly patients. The medicine should not be used in individuals with a prior history of jaundice or liver impairment linked to its use. Safety notes also state that symptoms of hepatic events may appear during or shortly after treatment, but sometimes several weeks after treatment has ceased, defining a time-related exposure pattern.

Overdose and Emergency Response

Overdose and when to seek help

The following information is derived strictly from government regulatory documentation concerning overdosage with Amoxicillin and Clavulanic acid.

Domain Official Regulatory Statement
Documented overdose presentations Overdose is commonly associated with acute gastrointestinal symptoms, including nausea, vomiting, and diarrhea. The most specific serious finding reported is amoxicillin crystalluria, which may present as cloudy or bloody urine or decreased urination. Central nervous system effects, such as convulsions, have also been documented.
Physiological systems affected The renal, gastrointestinal, and central nervous systems are the primary systems cited in official overdose documentation.
Population-specific overdose notes Individuals with pre-existing impaired renal function are at an elevated risk for severe outcomes due to the drug's primary elimination pathway.
Emergency-response statements Management requires immediate discontinuation of the medication, the institution of symptomatic treatment, and supportive measures. Adequate fluid intake and diuresis should be maintained to reduce the risk of crystalluria. For drug removal from the circulation, hemodialysis is an officially described procedure.

Official overdose statements:

  • Overdose typically presents with gastrointestinal symptoms (nausea, vomiting, diarrhea).
  • Amoxicillin crystalluria, which can lead to renal failure, is a primary documented complication.
  • Convulsions are reported as a severe neurological manifestation.

Official regulatory documents define the overdose profile primarily by the risk of amoxicillin crystalluria and acute neurological severity, such as convulsions. Accordingly, the label dictates that immediate medical attention must be sought, enabling necessary supportive care, close monitoring of renal function, and, where appropriate, the use of hemodialysis as a required procedural intervention.

Therapeutic Uses of Арлет

What Арлет Treats: Main Uses and Benefits

The Amoxicillin/Clavulanate combination is applied across domains where additional symptomatic support is needed, relevant in contexts involving heightened systemic burden. It is used for managing symptoms associated with conditions such as Lower Respiratory Tract Infections, Acute Bacterial Otitis Media, Sinusitis, Skin and Skin Structure Infections, and Urinary Tract Infections.

This medication is commonly used across conditions presenting with acute episodes, helping to address symptom clusters that may become intense or disruptive, such as symptoms related to systemic imbalance, inflammation, or organ-specific functional stress. When symptoms interfere with daily functioning, this supportive treatment contributes to easing the overall symptom load and may assist with coping more steadily during symptomatic phases. It is generally used in clinical scenarios that involve acute or unstable symptom patterns, including infections following trauma or oral surgery.

Quick Fact: Support for Symptoms Related to Heightened Physiological Strain

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Арлет — Official Regulatory Information

Populations for whom use is contraindicated:

  • Individuals with a history of serious hypersensitivity (e.g., anaphylaxis) to penicillins or other beta-lactam agents.
  • Patients with a prior history of cholestatic jaundice or liver dysfunction specifically associated with Amoxicillin/Clavulanate use.
  • Specific high-strength formulations are contraindicated in patients with severe renal impairment (Glomerular Filtration Rate < 30 mL/min) or those on hemodialysis.

Age and Condition-Specific Eligibility:

  • Established Use: Approved for adults, adolescents ge 40 kg, and pediatric patients 3 months/12 weeks and older.
  • Infants < 12 weeks: Use is restricted to specific, low-concentration oral suspension formulations.
  • Comorbidity Restriction: The medicine should be avoided in patients with Infectious Mononucleosis due to rash risk, and certain formulations are not permitted for patients with Phenylketonuria (PKU) if they contain aspartame.
  • Organ Function: Use requires caution in patients with hepatic impairment, and monitoring is recommended. The 875 mg dose is not permitted in severe renal impairment.
  • Reproductive Status: Use during pregnancy is generally considered conditional, and use during lactation is typically regarded as compatible.

What should I know about interactions with other medicines?

The established interaction profile for Арлет (Amoxicillin/Clavulanate) is delineated by regulatory authorities, focusing on specific pharmacokinetic and pharmacodynamic alterations that occur during co-administration with other substances.

Pharmacokinetic and Exposure Interactions

  • Probenecid: Co-administration is formally not recommended. This substance delays the renal clearance of Amoxicillin by inhibiting its tubular secretion pathway, which results in significantly increased and prolonged concentrations of Amoxicillin in the bloodstream.
  • Oral Contraceptives: Official labeling notes that Арлет may reduce the efficacy of combined oral estrogen/progesterone contraceptives by potentially disrupting the enterohepatic recirculation of estrogen.

Pharmacodynamic Risk Amplification

  • Oral Anticoagulants: Concomitant use with agents such as Warfarin may prolong the prothrombin time (INR), and official regulatory documents require appropriate monitoring when these agents are prescribed concurrently.
  • Allopurinol: Concurrent administration is associated with a substantially increased incidence of skin rash compared to Amoxicillin alone.

Administration Constraint

The regulatory profile notes a drug-food requirement: the absorption of Clavulanate is enhanced when administered with food. Therefore, the product is advised to be taken at the start of a meal to optimize absorption and reduce potential for gastrointestinal intolerance. Specific caution is also documented for co-administration in patients with evidence of hepatic dysfunction.

Mechanism of Action

The Primary Bactericidal Mechanism: Cell Wall Synthesis Inhibition

The antibiotic component, Amoxicillin, exerts its action by selectively targeting bacterial Penicillin-Binding Proteins (PBPs)—enzymes involved in cell wall construction. By forming a stable, covalent bond with PBPs, the drug halts the critical cross-linking step of the peptidoglycan pathway. This inhibition leads to structural instability and rupture (lysis) of the bacterial cell.

Augmentation by Enzymatic Defense Neutralization

This mechanism is augmented by the second component, Clavulanic acid, which maintains activity against resistant strains. Clavulanic acid acts as a suicide inhibitor that permanently neutralizes the beta-Lactamase enzymes produced by bacteria to degrade the antibiotic. This strategic action ensures that high concentrations of active Amoxicillin are preserved to facilitate its bactericidal mechanism.

Mechanistic Boundaries and Constraints

The mechanism's activity is confined by the specific molecular targets it engages. The drug does not act against resistance mechanisms that stem from structural changes to the PBPs themselves, nor is it effective against bacteria that employ defense methods other than beta-Lactamase production, such as efflux pumps.

Dosage and Administration Information

How Арлет is Used: Administration and Dosing

Арлет (Amoxicillin/Clavulanate) is consistently administered via the Oral route, available in several formulations including immediate-release tablets, extended-release tablets, and oral suspension. All dosing recommendations are based on the amoxicillin component, with the goal of ensuring the clavulanic acid component does not exceed a maximum amount per dose, typically 125 mg.

Administration Requirements

Category Instruction
Timing in relation to meals Must be taken at the start of a meal to enhance the absorption of clavulanic acid and minimize gastrointestinal intolerance.
Frequency and Schedule Standard adult dosing involves intervals of every 8 hours or every 12 hours depending on the formulation and prescribed amount, with the latter often used for less severe infections or higher doses.
Duration and Limits The course of treatment typically lasts 7 to 14 days. Administration should not be extended beyond 14 days without medical review.
Special Handling Oral suspension must be reconstituted with water by the dispenser and shaken well before each measured dose is administered. Extended-release tablets must not be crushed or chewed and must be swallowed whole.

Population-Specific Dosing

Dosing requires adjustment for patients with reduced kidney function. For individuals with a creatinine clearance (CrCl) of less than 30 mL/min, formulations containing 875 mg of amoxicillin are generally not recommended. Lower-dose immediate-release forms are used in these populations with a decreased frequency (e.g., every 12 or 24 hours) to prevent accumulation of the active ingredients. For pediatric patients weighing less than 40 kg, the dose is calculated based on body weight, typically ranging from 20 to 45 mg/kg/day.

Recent Clinical Evidence

Research Evidence Overview

This section focuses on the clinical studies conducted for the Amoxicillin/Clavulanate combination (Арлет) by medical researchers and regulatory bodies. The overview details the structure of the evidence base, including the types of studies performed, the populations they focused on, and the specific outcomes that were monitored, without making claims about expected results or individual treatment responses.


Evidence for use in Lower Respiratory Tract Infections (LRTIs)

The research for this indication is primarily composed of Randomized Controlled Trials (RCTs) and supporting Systematic Reviews that examined adult and older adult populations. Studies explored short-term outcomes related to the course of the infection. Researchers monitored several key measures, including the rate of clinical cure (e.g., patient-reported symptom changes), radiological improvement, and whether the targeted bacteria were bacteriologically eradicated from the site of infection.

Evidence for use in Acute Bacterial Otitis Media (ABOM)

The evidence base for ear infections largely stems from short-term RCTs and Meta-analyses conducted in pediatric populations (infants and children). These studies explored the short-term symptom patterns associated with acute episodes. Researchers primarily measured the rate of clinical success (resolution of signs) and monitored the bacteriological eradication of common pathogens from the middle ear fluid.

Evidence Gaps and Areas for Ongoing Research

The collective research highlights several areas where more data is needed to enhance the broader evidence landscape. A significant research limitation involves the continuous challenge of bacterial resistance, where studies must consistently be updated to address new resistant strains and changing regional patterns. Evidence for outcomes extending significantly beyond the initial short-term course remains limited, meaning long-term outcomes are not fully established regarding durability or recurrence rates.

Key Studies & References

  1. Clavulanic Acid - StatPearls (NIH Bookshelf)
  2. World Health Organization (WHO) Model List of Essential Medicines

Frequently Asked Questions (FAQ)

Common questions about Арлет (FAQ)

Q: How quickly should I expect to feel better after starting to take Арлет?

According to official product information, the antibiotic component of Арлет starts working against the bacteria within a few hours of the first dose. However, a noticeable improvement in patient-reported symptoms may not occur until a few days into the course of treatment, as the medication requires time to successfully reduce the infection.


Q: Does Арлет work immediately, or does it take a few days to reach full effectiveness?

The drug begins its action immediately at the molecular level, targeting and killing bacteria within hours of administration. However, the period required for the drug to reach the necessary concentration to have its full effect on clinical symptoms typically takes a few days.


Q: Is there a risk of developing a rash or skin sensitivity while on Арлет?

Yes, skin rash is a commonly reported side effect associated with the use of this drug. Regulatory warnings indicate that the medication should not be used by individuals with Infectious Mononucleosis due to a documented increase in the risk of a severe rash.


Q: What are the signs of a severe or allergic reaction to Арлет that require immediate attention?

Official regulatory documents list signs documented in the product labeling that may indicate a severe or life-threatening reaction. These include swelling of the face, lips, tongue, or throat; difficulty breathing, wheezing, or significant shortness of breath; and the development of hives or a severe, peeling skin rash.


Q: Is it common for Арлет to cause headaches?

Official product documentation classifies headaches as an Uncommon side effect. This means that they are reported by a small percentage of people who take the medicine, and they are not listed among the most frequently reported adverse reactions.


Q: Can taking Арлет make me feel dizzy or drowsy?

Dizziness is listed as a possible adverse reaction in official product labeling. Furthermore, other Central Nervous System effects, such as agitation, anxiety, and confusion, have also been reported by patients taking this medication.


Q: What happens if I forget to take a dose of Арлет?

Official patient information often provides guidance based on the time elapsed since the missed dose. If less than half the time has passed until the next scheduled dose, the guidance usually advises taking the missed dose promptly. If more than half the time has passed, skipping the missed dose and resuming the normal schedule is typically advised. The guidance consistently warns against taking a double dose.


Q: Is Арлет safe for children to take, and are the dosages different?

The drug is indicated for use in pediatric patients over specific age and weight thresholds. According to official dosing guidance, the dose for children under 40 kg is calculated based on their body weight, and some of the higher-strength tablet formulations are not approved for use in younger patients.


Q: Will Арлет work if the infection is caused by a virus?

Official prescribing information strictly states that Арлет is an antibacterial agent. It is not effective against infections caused by viruses, such as the common cold or flu, as it is strictly an antibacterial agent.


Q: Can taking Арлет affect my mood or cause feelings of anxiety?

Regulatory documents list a variety of Central Nervous System adverse reactions. These have included reports of changes in behavior, agitation, and anxiety, among other effects.


Q: Is there a generic version of Арлет available?

Yes, regulatory databases confirm that this combination drug is available under its official generic name, Amoxicillin and Clavulanate Potassium. Generic versions contain the same active ingredients and meet the same regulatory standards as the original brand-name product.


Q: What is the average duration of treatment with Арлет?

Official dosing guidelines state that the usual course of treatment is not to exceed 14 days. The most common treatment length falls within the range of seven to fourteen days, depending on the type and severity of the infection being treated.


Q: Are there any high-level differences between the tablet and liquid forms of Арлет (if applicable)?

Yes, the different forms are not chemically identical. Official guidance highlights that there are different ratios of the two active ingredients (Amoxicillin:Clavulanate) depending on the form, and some forms, like extended-release tablets, are restricted to specific patient groups and types of infection.


Q: Is Арлет used to treat skin infections?

Official regulatory indications confirm that Арлет is prescribed for the treatment of skin and skin structure infections. Specifically, it targets infections caused by certain susceptible bacteria that produce beta-lactamase enzymes.


Q: Will I need follow-up lab tests after finishing a course of Арлет?

Official warnings note that hepatic function (liver activity) should be monitored at regular intervals in patients with existing liver impairment. However, routine follow-up lab tests for all patients who have completed treatment are not specifically mandated across all regulatory guidelines.


Q: Is it possible to be resistant to the effects of Арлет?

While the combination drug is specifically designed to overcome resistance caused by beta-lactamase enzymes, other forms of bacterial resistance still exist. Official warnings advise against using the drug if lab tests indicate a lack of beta-lactamase production, as this suggests resistance may stem from other mechanisms.


Q: Does the age of the patient influence the side effects of Арлет?

Yes, regulatory documents indicate a difference in the risk profile based on age. It is noted that hepatic events, which are liver-related problems, have been reported more commonly in elderly patients and in males.


Q: Can Арлет cause insomnia or affect sleep patterns?

Yes, insomnia, or difficulty sleeping, is explicitly listed as a potential adverse reaction in the regulatory documents, categorized under Central Nervous System disorders.


Q: Are there any known long-term side effects associated with repeated use of Арлет?

Research evidence indicates that long-term outcomes following extended or repeated use are not fully established in studies. Official warnings also note that hepatic events (liver problems) may appear during or shortly after treatment but sometimes even several weeks after treatment has ceased.

How should Арлет be stored and disposed of?

The official storage requirements for Арлет (Amoxicillin/Clavulanate) vary significantly by formulation.

Official Storage Requirements

Product Form Required Storage Condition Stability Constraint
Tablets / Dry Powder Controlled room temperature (20 C to 25 C). Keep in original, tightly closed container.
Reconstituted Suspension Refrigerator (2 C to 8 C). Must be discarded after 7-10 days and must not be frozen.

All forms of this medication must be stored out of the sight and reach of children. The regulatory documents state that unused or expired medicine must not be disposed of in household wastewater or general trash and must be handled according to local pharmaceutical waste disposal protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Арлет found in:

A-Z Index: